Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
250
NMPA:250
Drug Approvals
Bisoprolol Fumarate and Amlodipine Besilate Tablets
- Product Name
- 比索洛尔氨氯地平片
- Approval Number
- 国药准字H20254358
- Approval Date
- May 27, 2025
NMPA
Telmisartan and Amlodipine Tablets
- Product Name
- 替米沙坦氨氯地平片
- Approval Number
- 国药准字H20254324
- Approval Date
- May 27, 2025
NMPA
Compound Amino Acids Injection（18AA-Ⅶ）
- Product Name
- 复方氨基酸注射液(18AA-Ⅶ)
- Approval Number
- 国药准字H20253761
- Approval Date
- Apr 1, 2025
NMPA
Compound Glucose / Electrolytes Irrigation Solution for Craniocerebral Surgery
- Product Name
- 复方葡萄糖/电解质颅脑手术冲洗液
- Approval Number
- 国药准字H20253724
- Approval Date
- Mar 25, 2025
NMPA
Magnesium Sulfate, Sodium Sulfate and Potassium Sulfate Concentrate Oral Solution
- Product Name
- 硫酸镁钠钾口服用浓溶液
- Approval Number
- 国药准字H20253358
- Approval Date
- Feb 8, 2025
NMPA
Morinidazole and Sodium Chloride Injection
- Product Name
- 吗啉硝唑氯化钠注射液
- Approval Number
- 国药准字H20249661
- Approval Date
- Dec 1, 2024
NMPA
Sodium Bicarbonate Injection
- Product Name
- 碳酸氢钠注射液
- Approval Number
- 国药准字H20247251
- Approval Date
- Oct 23, 2024
NMPA
- Prev
- 1
- 2
- 3
- 4
- 5
- 25
- Next
Clinical Trials
No trials found
News
No news found